Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 140
Filtrar
3.
Arch Gynecol Obstet ; 306(3): 593-622, 2022 09.
Artigo em Inglês | MEDLINE | ID: mdl-34825938

RESUMO

PURPOSE: Despite the vaginal mucosa is able to respond to allergenic stimuli, vaginal allergic responses have been under investigated in clinical practice. Thus, we aimed to identify the most frequent etiological agents responsible for vulvovaginal allergies, the prevalent signs/symptoms, and the diagnostic tests applied in this clinical condition. METHODS: Literature search was performed on PubMed, Scopus, Scielo, Web of Science, and EMBASE. The study protocol was registered on PROSPERO (CRD42020167238). Studies were divided in two groups depending on allergen exposure route. Due to a significant number of studies correlating allergy to Candida infection, subgroup analysis was included. RESULTS: In direct exposure cases, Human Seminal Plasma was the most prevalent allergen, sensitizing 73% of affected women. These women presented localized swelling and burning as prevalent symptoms, affecting 42/68 and 36/68 women, respectively. Cutaneous Prick tests were applied in 58/68 women, either alone or combined with IgE measurements. Regarding cases of indirect/unidentified exposure, house dust mites was the most prevalent allergen (54%), followed by pollen (44%). Predominant symptoms were vulvar pruritus and burning, affecting 67/98 and 52/98 women. Skin prick test was the most prevalent diagnostic method used among different studies. Hypersensitivity toward Candida antigen was present in only half (163/323) of women presenting concomitant allergy and Candida infection. CONCLUSION: From the two types of allergen exposure that can cause vulvovaginal allergic responses, direct contact of the antigen with the vulva and/or vagina was the most prevalent. Still, allergens can also sensitize the vaginal mucosa secondarily to other exposure route, specifically aeroallergens.


Assuntos
Candidíase , Hipersensibilidade , Vulvovaginite , Alérgenos , Feminino , Humanos , Hipersensibilidade/diagnóstico , Hipersensibilidade/epidemiologia , Testes Cutâneos , Vulvovaginite/epidemiologia
4.
Rev Iberoam Micol ; 38(3): 132-137, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34092515

RESUMO

BACKGROUND: Recurrent vulvovaginitis is a growing problem that affects millions of women worldwide. In many cases it is treated as vulvovaginal candidiasis, but there is not always microbiological confirmation. AIMS: To determine the etiology of vulvovaginitis in a group of patients. METHODS: This is a cross-sectional study in which the data from the medical records of 316 adult patients who consulted for vulvovaginitis were analyzed. Eighty nine percent of the cases had already suffered previous episodes. RESULTS: The median age was 34 (265 patients were between 16 and 45 years old). Yeasts were isolated in culture from 211 (66.8%) patients, although pseudo-hyphae and yeasts were observed in only 166 samples (52.5%) in the direct microscopic examination. Multiple predisposing factors were found, among which the use of contraceptives or previous antibiotics stand out. Most of the patients (almost 90%) had been treated with antifungals, with or without microbiological confirmation. Candida albicans was isolated in 187 (88.6%) patients, followed by Candida glabrata in 6 (2.8%) patients. Association with bacterial vaginosis was found in 35.1% and with intermediate bacterial microbiota in 33.2% of the cases. A remarkably high proportion of C. albicans isolates resistant to fluconazole (80.1%) and itraconazole (58.8%) was found. CONCLUSIONS: A microbiological analysis is essential to confirm the diagnosis of vulvovaginal candidiasis, whether simple, complicated, or recurrent. Identifying the isolated yeast species and determining its susceptibility to antifungal agents are particularly important.


Assuntos
Candidíase Vulvovaginal , Vulvovaginite , Adulto , Antifúngicos/farmacologia , Antifúngicos/uso terapêutico , Candida , Candidíase Vulvovaginal/tratamento farmacológico , Candidíase Vulvovaginal/epidemiologia , Estudos Transversais , Farmacorresistência Fúngica , Feminino , Fluconazol , Humanos , Testes de Sensibilidade Microbiana , Vulvovaginite/tratamento farmacológico , Vulvovaginite/epidemiologia
5.
Eur J Clin Microbiol Infect Dis ; 40(10): 2123-2128, 2021 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-33942163

RESUMO

Vulvovaginitis is a common problem in the GP's practice. Causes are bacterial vaginosis (BV), Candida infection and sexually transmitted infections (STIs). Only if empirical treatment fails, a vaginal swab is sent in for culture and BV detection. However, without culture essential, bacterial pathogens may escape diagnosis. Many molecular BV assays have recently appeared on the marketplace, all quite differing in price and targets. However, for years, the Nugent score has been the gold standard for BV detection. We analysed retrospectively 10 years of microbiology results of vulvovaginal swabs, focusing on less frequently reported bacterial pathogens, and assessed the characteristics of BV diagnostics. Vulvovaginal swabs sent in between 2010 and 2020 from > 11,000 GP patients with vulvovaginitis associated symptoms, but negative STI tests, were analysed. First cultures and repeat cultures after at least 6 months were included in four age groups: < 12, 12-17, 18-51 and > 51 years. Candida species and BV were most frequently found, with the highest prevalence in premenopausal women. Haemophilus influenzae, beta-haemolytic streptococci, Streptococcus pneumoniae and Staphylococcus aureus were isolated in 5.6% of all cultures, with the highest percentages in children and postmenopausal women. If empirical treatment of vulvovaginitis fails, bacterial culture should be performed to detect all potentially pathogenic microorganisms to obtain a higher rate of successful diagnosis and treatment, avoiding unnecessary antimicrobial use and costs. For BV detection, molecular testing may seem attractive, but Nugent scoring still remains the low-cost gold standard. We recommend incorporating the above in the appropriate guidelines.


Assuntos
Bactérias/isolamento & purificação , Descarga Vaginal/microbiologia , Vulvovaginite/microbiologia , Adolescente , Adulto , Bactérias/classificação , Bactérias/genética , Criança , Feminino , Humanos , Pessoa de Meia-Idade , Países Baixos/epidemiologia , Prevalência , Estudos Retrospectivos , Vagina/microbiologia , Descarga Vaginal/epidemiologia , Vulvovaginite/epidemiologia , Adulto Jovem
6.
Environ Sci Pollut Res Int ; 28(27): 35790-35797, 2021 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-33677663

RESUMO

As a cause of vulvovaginitis in prepubertal girls, Streptococcus pyogenes (S. pyogenes) is commonly isolated from vaginal introitus swabs. Studies have identified several risk factors, but have not focused on the correlation between ambient air pollutants and S. pyogenes-induced vulvovaginitis in prepubertal girls. This study was conducted to determine whether ambient air pollutants were associated with S. pyogenes-induced vulvovaginitis in prepubertal girls. Daily data about S. pyogenes-induced vulvovaginitis in prepubertal girls from the outpatient department of Children's Hospital at the Zhejiang University School of Medicine in Hangzhou City between January 1, 2015, and December 31, 2018, were retrospectively reviewed. Ambient air pollutants in Hangzhou were measured daily. A generalized additive model (GAM) was utilized to assess the associations between daily air pollutants and S. pyogenes isolates obtained from vaginal introitus swabs of prepubertal girls. The mean daily concentration of nitrogen dioxide (NO2) in Hangzhou City during the study period was 44.6 µg/m3 (25th-75th percentiles, 32.0-56.0 µg/m3). The GAM showed that the largest estimate effects in S. pyogenes-induced vulvovaginitis in prepubertal girls were found in NO2 with a moving (accumulative) average on day 3. The excess risk of NO2 in terms of the daily number of S. pyogenes isolates obtained from the vaginal introitus swabs was 14.91% (95% confidence interval [CI]: 4.85-25.94%) in the single-pollutant model. The multipollutant model revealed that an increase of 10 µg/m3 in NO2 exposure was associated with an 18.33% increased risk for acquiring S. pyogenes-induced vulvovaginitis in prepubertal girls (95% CI: 1.21-38.35%; P < 0.05). In conclusion, short-term NO2 exposure was strongly associated with the spread of S. pyogenes-induced vulvovaginitis in prepubertal girls.


Assuntos
Poluentes Atmosféricos , Poluição do Ar , Vulvovaginite , Poluentes Atmosféricos/análise , Poluição do Ar/análise , Criança , China/epidemiologia , Cidades , Feminino , Humanos , Dióxido de Nitrogênio/análise , Material Particulado/análise , Estudos Retrospectivos , Streptococcus pyogenes , Vulvovaginite/epidemiologia
7.
Front Immunol ; 10: 2034, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31555269

RESUMO

Recurrent vulvovaginal infections (RVVI), a devastating group of mucosal infection, are severely affecting women's quality of life. Our understanding of the vaginal defense mechanisms have broadened recently with studies uncovering the inflammatory nature of bacterial vaginosis, inflammatory responses against novel virulence factors, innate Type 17 cells/IL-17 axis, neutrophils mediated killing of pathogens by a novel mechanism, and oxidative stress during vaginal infections. However, the pathogens have fine mechanisms to subvert or manipulate the host immune responses, hijack them and use them for their own advantage. The odds of hijacking increases, due to impaired immune responses, the net magnitude of which is the result of numerous genetic variations, present in multiple host genes, detailed in this review. Thus, by underlining the role of the host immune responses in disease etiology, modern research has clarified a major hypothesis shift in the pathophilosophy of RVVI. This knowledge can further be used to develop efficient immune-based diagnosis and treatment strategies for this enigmatic disease conditions. As for instance, plasma-derived MBL replacement, adoptive T-cell, and antibody-based therapies have been reported to be safe and efficacious in infectious diseases. Therefore, these emerging immune-therapies could possibly be the future therapeutic options for RVVI.


Assuntos
Suscetibilidade a Doenças/imunologia , Interações Hospedeiro-Patógeno/imunologia , Vulvovaginite/etiologia , Imunidade Adaptativa , Feminino , Predisposição Genética para Doença , Interações Hospedeiro-Patógeno/genética , Humanos , Imunidade Inata , Estresse Oxidativo , Polimorfismo de Nucleotídeo Único , Receptores de Reconhecimento de Padrão/metabolismo , Recidiva , Vagina/imunologia , Vagina/metabolismo , Vagina/microbiologia , Vagina/patologia , Vulvovaginite/diagnóstico , Vulvovaginite/epidemiologia , Vulvovaginite/metabolismo
8.
Mycoses ; 62(11): 1043-1048, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31376228

RESUMO

The aim of this study was to estimate the annual burden of fungal infections in Sweden using data mainly from 2016. Data on specific populations were obtained from Swedish national data registries. Annual incidence and prevalence of fungal disease was calculated based on epidemiological studies. Data on infections due to Cryptococcus sp., Mucorales, Histoplasma capsulatum, Coccidioides immitis and Pneumocystis jirovecii were retrieved from Karolinska University Laboratory and covers only 25% of Swedish population. In 2016, the population of Sweden was 9 995 153 (49.8% female). The overall burden of fungal infections was 1 713 385 (17 142/100 000). Superficial fungal infections affect 1 429 307 people (1429/100 000) based on Global Burden of Disease 14.3% prevalence. Total serious fungal infection burden was 284 174 (2843/100 000) in 2016. Recurrent Candida vulvovaginitis is common; assuming a 6% prevalence in women. Prevalence of allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitisation were estimated to be 20 095 and 26 387, respectively. Similarly, chronic pulmonary aspergillosis was estimated to affect 490 patients after tuberculosis, sarcoidosis and other conditions. Candidemia incidence was estimated to be 500 in 2016 (4.7/100 000) and invasive aspergillosis 295 (3.0/100 000). In Stockholm area, Mucorales were reported in three patients in 2015, while Cryptococcus spp. were reported in two patients. In 2016, there were 297 patients PCR positive for P jirovecii. The present study shows that the overall burden of fungal infections in Sweden is high and affects 17% of the population. The morbidity, mortality and the healthcare-related costs due to fungal infections warrant further studies.


Assuntos
Efeitos Psicossociais da Doença , Micoses/epidemiologia , Adolescente , Idoso , Criança , Pré-Escolar , Dermatomicoses/epidemiologia , Dermatomicoses/microbiologia , Feminino , Humanos , Incidência , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Micoses/microbiologia , Prevalência , Infecções Respiratórias/epidemiologia , Infecções Respiratórias/microbiologia , Suécia/epidemiologia , Vulvovaginite/epidemiologia , Vulvovaginite/microbiologia
9.
N Z Vet J ; 67(5): 249-256, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31131738

RESUMO

Aims: To examine the association between the detection of Ureaplasma diversum in vaginal swabs from dairy cows in north western Spain with the diagnosis of granular vulvovaginitis (GVV) and reproductive performance, and the association with subclinical endometritis (SE) in slaughterhouse material. The presence of this microorganism in cases of abortion was also investigated. Methods: From 106 dairy farms in the province of Lugo, 40 herds were randomly selected. Vaginal swabs were obtained from 10 randomly selected cows per farm, then pooled for analysis to detect the presence of U. diversum by quantitative real-time PCR (qPCR). In five of these herds samples from the 10 animals were individually tested for U. diversum, and the presence of GVV lesions and their reproductive efficiency (number of inseminations to achieve pregnancy over two subsequent pregnancies) were determined. Vaginal swabs from uteri of cattle obtained at a slaughterhouse (n = 100) were tested for U. diversum and the presence of SE, defined as >5% polymorphonuclear cells in cytobrush smears, was determined. Sixteen farms with abortion problems submitted samples for culture and PCR testing including for U. diversum. Results: Of the 40 herds, 39 (98%) tested positive for U. diversum. On the five farms, 25/50 (50%) cows tested positive for U. diversum, and more cows with GGV-lesions (16/25; 64%) tested positive than cows without lesions (9/25; 36%) (p = 0.047). There were more cows with poor reproductive efficacy that tested positive (8/11; 57%) than tested negative (3/17; 18%) for U. diversum (p = 0.029). Of the 100 uteri, five tested positive for U. diversum and there were more uteri with SE that tested positive (3/19; 16%) than uteri without SE (2/81; 2%) (p = 0.036). U. diversum was also diagnosed in 4/16 farms with abortion problems and liver appeared to be the best tissue for detecting U. diversum DNA in the fetuses analysed. Conclusions and Clinical Relevance: Infection with U. diversum was present in most of herds investigated and it was statistically associated with GVV, SE and poor reproductive performance. It was also detected in abortions and the liver may also be an additional tissue to be considered in the diagnosis of U. diversum abortion by PCR. The possible association with different diseases in the same area suggests that different presentations should be considered when studying the implications of U. diversum on the reproductive diseases of cattle.


Assuntos
Aborto Animal/microbiologia , Doenças dos Bovinos/epidemiologia , Doenças dos Bovinos/microbiologia , Endometrite/veterinária , Infecções por Ureaplasma/veterinária , Vulvovaginite/veterinária , Aborto Animal/epidemiologia , Criação de Animais Domésticos , Animais , Bovinos , Indústria de Laticínios , Endometrite/epidemiologia , Endometrite/microbiologia , Feminino , Modelos Logísticos , Reação em Cadeia da Polimerase , Gravidez , Espanha/epidemiologia , Ureaplasma/isolamento & purificação , Infecções por Ureaplasma/epidemiologia , Esfregaço Vaginal/veterinária , Vulvovaginite/epidemiologia , Vulvovaginite/microbiologia
10.
J Int Med Res ; 47(6): 2626-2636, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31088247

RESUMO

OBJECTIVE: To evaluate the acceptability, tolerability, and effects on vulvovaginitis symptoms and signs of a non-soap, herbal-based intimate solution (Zelesse®). METHODS: We conducted a prospective, observational, multicenter study including adult women with symptoms and signs of vulvovaginitis with various etiologies, including candidiasis, trichomoniasis, bacterial vaginosis, and atrophic and irritative vaginitis. The presence and intensity of signs (edema, erythema, vaginal discharge) and symptoms (pruritus) of vulvovaginitis were evaluated before and after 5-15 days of daily use of Zelesse® alone or as a coadjuvant in antimicrobial therapy. Variables following a normal distribution and categorical variables were analyzed using the Student t-test and chi-square or Fisher's exact test, respectively. RESULTS: A total 137 women were enrolled in the study; 87 (63.5%) women received concomitant antimicrobials and 50 (36.5%) used Zelesse® only. Global symptom scores and frequency of patients with vulvovaginitis signs and symptoms, and their mean intensity, decreased after treatment in both patient groups. Vaginal pH and (in the Zelesse®-only group) vaginal flora remained unaltered. The product was safe, well tolerated, and highly accepted by patients. CONCLUSIONS: Zelesse®, the non-soap herbal-based solution in this study, may represent a safe and effective option for symptomatic relief of vulvovaginitis.


Assuntos
Antibacterianos/uso terapêutico , Fitoterapia , Índice de Gravidade de Doença , Soluções/administração & dosagem , Vulvovaginite/tratamento farmacológico , Vulvovaginite/patologia , Adulto , Feminino , Seguimentos , Humanos , Higiene , Masculino , Dose Máxima Tolerável , Prognóstico , Estudos Prospectivos , Espanha/epidemiologia , Vulvovaginite/epidemiologia
11.
J Vet Diagn Invest ; 30(3): 464-467, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29429402

RESUMO

A group of Holstein first-calved heifers developed small pustules and ulcers on the vulva and in the vagina during the first 1-4 wk postpartum. The lesions varied from small red pinpoint foci to pustules and ulcers, 3-5 mm diameter. Some ulcers coalesced to form large ulcerated areas up to 15 mm diameter. In some animals, these ulcers progressed to become deep ulceration of the vaginal and vulvar mucosa with >50% of the mucosa involved. Vaginal biopsies from 4 heifers and vaginal individual swabs from 8 heifers for a combined sampling of 9 heifers were taken for clinical assessment. Six of the 9 heifers had parapoxvirus based on histopathology and/or PCR. Histologic examination of the biopsies of the pustules identified ballooning degeneration of the epithelium with degenerate epithelium containing eosinophilic intracytoplasmic inclusions consistent with a parapoxvirus in 3 of 4 biopsies. Testing for bovine herpesvirus 1, 2, and 4, bovine viral diarrhea virus, bovine papular stomatitis virus, and orf virus remained negative.


Assuntos
Doenças dos Bovinos/epidemiologia , Surtos de Doenças/veterinária , Parapoxvirus/isolamento & purificação , Infecções por Poxviridae/veterinária , Vulvovaginite/veterinária , Animais , Animais Recém-Nascidos , California/epidemiologia , Bovinos , Doenças dos Bovinos/patologia , Doenças dos Bovinos/virologia , Indústria de Laticínios , Feminino , Parapoxvirus/genética , Reação em Cadeia da Polimerase/veterinária , Infecções por Poxviridae/epidemiologia , Vulvovaginite/epidemiologia
12.
Prev Vet Med ; 150: 126-132, 2018 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-29406079

RESUMO

Bovine herpesvirus-1 (BHV-1) causes infectious bovine rhinotracheitis (IBR), and infectious pustular vulvovaginitis (IPV) in cows and infectious pustular balanopostitis (IPB) in bulls worldwide. Infection of seronegative cattle with BHV-1 leads to abortion, retention of fetal membranes, increased service per conception, metritis and oophoritis. As part of an ongoing study on infectious causes of reproductive disorders in Ethiopia, this investigation aims at assessing the role of BHV-1 in the disorders and the risk factors affecting its seroprevalence. A cross-sectional study was conducted on a total of 1379 randomly selected dairy cattle from 149 herds. These dairy cattle were sampled from milks sheds of central (n = 555), western (n = 195) and southern (n = 629) Ethiopia. Blocking enzyme-linked immunosorbent assay (B-ELISA) was applied to detect antibodies specific to BHV-1. Additionally, a semi-structured questionnaire was administered and farm records were assessed to capture potential risk factors associated with BHV-1 seropositivity. Univariable and multivariable random-effects logistic regression analyses were used to assess potential risk factors associated with BHV-1 serostatus. Model fitness and reliability were assessed using the Hosmer and Lemeshow method and the receiver operating curve (ROC) respectively. An overall herd level BHV-1 seroprevalence of 81.8% (95% confidence interval (CI): 74.7-87.7%) and individual animal level seroprevalence of 41.0% (95% CI: 38.4-43.7%) were found. In a random-effects multivariable logistic regression model, the seroprevalence of BHV-1 exposure was higher in dairy cattle from breeding (Odds ratio [OR] = 1.3; p = 0.036) than in commercial (OR = 0.9; p = 0.137) and small-holder farms. Geographically, the prevalence was higher in western (OR = 1.4; p < 0.001) and southern Ethiopia (OR = 1.2; p < 0.001) than in central regions. BHV-1 seropositive cows had higher (p < 0.05) odds of clinical reproductive disorders including abortion, retained fetal membranes, stillbirth, birth of weak calf and metritis compared to seronegative cows. Thus, it is suggested that BHV-1 should be considered as differential diagnosis among improved dairy cattle herds with reproductive disorders in Ethiopia.


Assuntos
Herpesvirus Bovino 1/isolamento & purificação , Rinotraqueíte Infecciosa Bovina/epidemiologia , Doenças do Pênis/veterinária , Vulvovaginite/veterinária , Animais , Bovinos , Estudos Transversais , Ensaio de Imunoadsorção Enzimática , Etiópia/epidemiologia , Feminino , Rinotraqueíte Infecciosa Bovina/virologia , Masculino , Doenças do Pênis/epidemiologia , Doenças do Pênis/virologia , Prevalência , Fatores de Risco , Estudos Soroepidemiológicos , Vulvovaginite/epidemiologia , Vulvovaginite/virologia
13.
J Vet Diagn Invest ; 30(2): 256-259, 2018 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-29153035

RESUMO

Species Pseudocowpox virus (PCPV; family Poxviridae) is known to cause pustular cutaneous disease in cattle. We describe an outbreak of pseudocowpox with an unusual clinical picture in a free-stall dairy herd of ~80 cows. Approximately 90% of the cows had vesicles, erosions, papules, and scabs on the vulva and vaginal mucosa. Histologic analysis of biopsy tissues indicated a primary, although not specified, viral infection. Transmission electron microscopy revealed parapoxvirus particles in both tissue and vesicular materials. Deep sequencing analysis of extracted DNA from swabbed vesicle areas gave a contig of nearly 120,000 nucleotides, matching the PCPV strain VR 634 with 100% identity. Analyses confirmed the absence of other potential causes of pustular vulvovaginitis such as bovine herpesvirus 1 and Ureaplasma diversum. A rolling cow brush was suspected to be the fomite.


Assuntos
Doenças dos Bovinos/epidemiologia , Surtos de Doenças/veterinária , Infecções por Poxviridae/veterinária , Vírus da Pseudovaríola das Vacas/isolamento & purificação , Vulvovaginite/veterinária , Animais , Bovinos , Doenças dos Bovinos/patologia , Doenças dos Bovinos/virologia , Indústria de Laticínios , Feminino , Infecções por Poxviridae/epidemiologia , Suécia/epidemiologia , Vulvovaginite/epidemiologia
14.
JAMA Surg ; 152(5): 436-441, 2017 05 01.
Artigo em Inglês | MEDLINE | ID: mdl-28114513

RESUMO

Importance: Identification of risk factors for adverse obstetrical outcomes after appendectomy and cholecystectomy during pregnancy is necessary for evidence-based risk reduction and adequate patient counseling. Objectives: To identify risk factors for adverse obstetrical outcomes after appendectomy and cholecystectomy during pregnancy and stratify the risk of such outcomes. Design, Setting, and Participants: A cohort study was conducted using the Nationwide Inpatient Sample, a nationally representative sample of patients discharged from community hospitals in the United States, from January 1, 2003, to December 31, 2012. Multivariable analysis of risk factors for adverse obstetric outcomes was performed for 19 926 women undergoing appendectomy or cholecystectomy during pregnancy and a scoring system for such risk factors was developed. Data analysis was conducted from January 1, 2015, to July 31, 2016. Main Outcomes and Measures: A composite measure including 7 adverse obstetrical outcomes throughout pregnancy and occurring before hospital discharge. Results: Of the 19 926 women (mean [SD] age, 26 [6] years) in the study, 1018 adverse obstetrical events were recorded in 953 pregnant women (4.8%). The 3 most frequent adverse events were preterm delivery (360 [35.4%]), preterm labor without preterm delivery (269 [26.4%]), and miscarriage (262 [25.7%]). The risk factors associated most strongly with an adverse obstetrical outcome included cervical incompetence (adjusted odds ratio, 24.29; 95% CI, 7.48-78.81), preterm labor during current pregnancy (adjusted odds ratio, 18.34; 95% CI, 4.95-67.96), vaginitis or vulvovaginitis (adjusted odds ratio, 5.17; 95% CI, 2.19-12.23), and sepsis (adjusted odds ratio, 3.39; 95% CI, 2.08-5.51). A scoring system based on statistically significant variables classified the study sample into 3 risk groups corresponding to predicted probabilities of adverse obstetrical outcomes of 2.5% (≤4 points), 8.2% (5-8 points), and 21.8% (≥9 points). Conclusions and Relevance: Approximately 5% of women experience adverse obstetrical outcomes after appendectomy or cholecystectomy during pregnancy. The major risk factors for such outcomes are cervical incompetence, preterm labor during current pregnancy, vaginitis or vulvovaginitis, and sepsis.


Assuntos
Aborto Espontâneo/epidemiologia , Apendicectomia/efeitos adversos , Colecistectomia/efeitos adversos , Trabalho de Parto Prematuro/epidemiologia , Nascimento Prematuro/epidemiologia , Aborto Espontâneo/etiologia , Adulto , Estudos de Coortes , Feminino , Humanos , Trabalho de Parto Prematuro/etiologia , Gravidez , Nascimento Prematuro/etiologia , Medição de Risco , Fatores de Risco , Sepse/epidemiologia , Estados Unidos/epidemiologia , Incompetência do Colo do Útero/epidemiologia , Vulvovaginite/epidemiologia , Adulto Jovem
17.
Trop Anim Health Prod ; 49(2): 311-316, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27915439

RESUMO

Ureaplasma diversum infection in bovine females may result in various reproductive problems, including granular vulvovaginitis, abortion, weak calves, salpingitis, and spontaneous abortion. The presence of U. diversum in a dairy bovine population from midwestern Brazil has not been established. The aim of this study was to determine whether U. diversum was present in dairy cattle from midwestern Brazil using polymerase chain reaction (PCR). Vulvovaginal mucus was analyzed from 203 cows located in six municipalities in the north region of Mato Grosso State, Brazil. A total of 25% of dairy cows with vulvovaginitis were positive for U. diversum. The factors evaluated were included in a multivariable logistic regression model with the presence of at least one positive cow in the herd serving as the dependent variable. Three variables were significantly associated with a U. diversum-positive PCR and were included in the final multivariable model: number of parities, vulvar lesions, and reproductive problems. For each new parity, the chance of U. diversum infection decreased 0.03-fold, indicating that cows with the highest number of parities were more protected. The presence of vulvar lesions was increased 17.6-fold in females positive for U. diversum, suggesting that this bacterium could be related to the red granular lesions in the vulvar mucosa, whereas reproductive problems were increased 7.6-fold. However, further investigations should be conducted to ascertain the effects of U. diversum in association with other mycoplasma species in the herds studied.


Assuntos
Doenças dos Bovinos/epidemiologia , Infecções por Ureaplasma/veterinária , Ureaplasma/isolamento & purificação , Vulvovaginite/veterinária , Aborto Animal/epidemiologia , Animais , Brasil/epidemiologia , Bovinos , Doenças dos Bovinos/microbiologia , Indústria de Laticínios , Feminino , Reação em Cadeia da Polimerase/veterinária , Gravidez , Ureaplasma/genética , Infecções por Ureaplasma/epidemiologia , Infecções por Ureaplasma/microbiologia , Vulvovaginite/epidemiologia , Vulvovaginite/microbiologia
18.
Pediatr Int ; 59(4): 432-437, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27638252

RESUMO

BACKGROUND: Streptococcus pyogenes (group A Streptococcus) is the etiological agent of perineal infection in children, consisting of perianal infection, vulvovaginitis and balanitis. If it is not properly diagnosed and treated, it can persist for many months and can cause severe complications. Furthermore, treatment with penicillin can be followed by failures and recurrences. METHODS: We report here the prevalence of S. pyogenes isolates in genital tract specimens from girls (n = 1692) with symptoms of vulvovaginitis and from boys (n = 52) with balanitis in the municipality of Nis, Southeast-Serbia (the Western Balkans) in a 10 year period, and the seasonal distribution, patient age and sensitivity to bacitracin and antimicrobial drugs used in the treatment of streptococcal infection. RESULTS: Streptococcal vulvovaginitis was diagnosed in 2.30% of examinees. Of those cases, 64.10% were detected from April to September, and it was most common (71.79%) in girls aged 3-7 years. Streptococcal balanitis was diagnosed in two instances: in a 4-year-old boy and in a 7-year-old boy. S. pyogenes strains resistant to bacitracin were identified in five girls. Two isolates with M phenotype and five isolates with cMLSB phenotype were identified. CONCLUSIONS: Streptococcal vulvovaginitis was diagnosed less often in the present study, but it was still far more common than streptococcal balanitis in childhood. Bacitracin resistance of S. pyogenes strains should be taken into account in routine microbiological identification, and the detection of S. pyogenes isolates resistant to erythromycin requires surveillance in the present geographical territory.


Assuntos
Balanite (Inflamação)/microbiologia , Infecções Estreptocócicas/epidemiologia , Streptococcus pyogenes/isolamento & purificação , Vulvovaginite/microbiologia , Balanite (Inflamação)/diagnóstico , Balanite (Inflamação)/epidemiologia , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Prevalência , Sérvia/epidemiologia , Infecções Estreptocócicas/diagnóstico , Vulvovaginite/diagnóstico , Vulvovaginite/epidemiologia
19.
J Pak Med Assoc ; 66(4): 387-92, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27122262

RESUMO

OBJECTIVE: To determine the frequency, associated factors and relationship with vulvovaginal symptoms and vaginal douching among Turkish women. METHODS: The cross-sectional, analytical study was conducted at Merkez Efendi Hospital, Manisa, Turkey, from January to June 2014 using a questionnaire. Statistical analysis was carried out using SPSS 17. RESULTS: Of the total 343 women in the study, 91(26.5%) had reported vaginal douching in the preceding year. Statistically significant relationship was determined between the vaginal douching behaviour and couples who had low educationand low income levels, having unplanned pregnancy and had someone in their neighbourhood who douched (p< 0.05 each). The most common reason for using vaginal douching was reported to be cleanliness by 85(93.4%) women, prevention of genital infections 75(82.4%), cleaning after/before sexual intercourse 72(79%), during menstruation 49(54%), prevention of vaginal discharge 69(76%), decreasing of unpleasant odours 65(71.4%) and religious beliefs 46(50.5%). Self-reported history of vaginal infection was significantly more common for women who douched compared those who did not (p< 0.05). CONCLUSIONS: Healthcare providers should determine the reason and risky groups of women and educate the women to stop the vaginal douching behaviour and harmful effects of vaginal douching.


Assuntos
Conhecimentos, Atitudes e Prática em Saúde , Ducha Vaginal/estatística & dados numéricos , Adulto , Candidíase Vulvovaginal/epidemiologia , Estudos Transversais , Dispareunia/epidemiologia , Escolaridade , Feminino , Humanos , Higiene , Renda/estatística & dados numéricos , Dor Pélvica/epidemiologia , Religião , Inquéritos e Questionários , Turquia/epidemiologia , Descarga Vaginal/epidemiologia , Vulvovaginite/epidemiologia , Adulto Jovem
20.
Mycoses ; 59(7): 429-35, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26931504

RESUMO

To evaluate the frequency of yeast, bacteria or protozoa in pregnant women and to correlate the possible associations of these microorganisms and their relationships with vulvovaginitis (VV) and cervicitis. Vaginal specimens were collected and prepared for smears in microscope slides for the evaluation of yeast, Trichomonas vaginalis and bacteria. Samples were cultured in specific culture medium. Cervical specimens were used to investigate the presence of Neisseria gonorrhoeae, Chlamydia trachomatis, Ureaplasma spp. and Mycoplasma hominis. We enrolled 210 pregnant women, aged 10-42 years old. Of them, 38.1% were symptomatic. Symptoms were most prevalent in the second and third trimesters of pregnancy coincident with a major prevalence of microorganisms. In this study, 39.5% of pregnant women had normal microbial biota and symptoms of VV due to non-infectious causes were observed (6.2%). The occurrence of vulvovaginal candidiasis was 25% and Candida albicans with a prevalence of 80.7% was the dominant species (P = 0.005) while non-albicans Candida species and other yeast were more common in asymptomatic ones (P = 0.0038). The frequency of bacterial vaginosis, T. vaginalis, C. trachomatis and N. gonorrhoeae were 18.1%, 1.4, 1.4% and 0.5% respectively.


Assuntos
Candida albicans/isolamento & purificação , Candidíase Vulvovaginal/epidemiologia , Candidíase Vulvovaginal/microbiologia , Complicações Infecciosas na Gravidez/epidemiologia , Vulvovaginite/epidemiologia , Adolescente , Adulto , Argentina/epidemiologia , Infecções Assintomáticas/epidemiologia , Candidíase Vulvovaginal/diagnóstico , Colo do Útero/microbiologia , Criança , Feminino , Humanos , Mycoplasma/isolamento & purificação , Neisseria gonorrhoeae/isolamento & purificação , Gravidez , Complicações Infecciosas na Gravidez/microbiologia , Prevalência , Estudos Prospectivos , Trichomonas vaginalis/isolamento & purificação , Ureaplasma/isolamento & purificação , Cervicite Uterina/epidemiologia , Cervicite Uterina/microbiologia , Vagina/microbiologia , Vaginose Bacteriana/epidemiologia , Vaginose Bacteriana/microbiologia , Vulvovaginite/diagnóstico , Vulvovaginite/microbiologia , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...